"India is a strategic growth market for Takeda, and we are making significant long-term investments... in terms of innovation and building capabilities," said Annapurna Das, the general manager of Takeda's India operations.
Takeda eyes India for global clincal trials amid booming clinical trials market
Advertisement
New Delhi: Japanese pharmaceutical giant Takeda is considering conducting global clinical trials in India as part of a broader strategy to accelerate the launch of its innovative drugs in the world's most populous nation, its India head told Reuters.
In addition to trials, Takeda is also open to partnerships with local academia, healthcare providers, and technology firms in India to boost innovation, Das said.
The plan comes at a time when India's clinical trials market is growing, powered by diverse patient pools, cost efficiency, and a fast-growing hospital network. Grand View Research expects the market to exceed $2 billion by 2030.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.